Avita Medical is a medical device company that provides a unique approach to skin regeneration



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Our patented and proprietary collection and application technology provides innovative treatment solutions derived from a patient’s own skin to treat a wide range of wounds, scars and skin defects. Our devices create a Regenerative Epithelial Suspension (RES™) – an autologous suspension comprised of the cells and wound healing factors necessary to regenerate natural healthy skin.

Avita’s regenerative product portfolio includes ReCell® for burns aimed at plastic reconstructive procedures, ReGenerCell™ for chronic wounds and ReNovaCell™ for the restoration of pigmentation.

Read more



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Read more


7,694

Procedures

32

Market Approvals

64

Published Papers

47%

reduction in hospital stay20

38%

reduction in donor skin21

ReCell® is a medical device that enables medical professionals to collect cells from a small sample of a patient’s own skin to create a suspension that can regenerate wounds caused by burns.

55%

reduction in wound area in 4 weeks2

33%

pain reduction in one week7

ReGenerCell™ is a medical device that allows medical professionals to swiftly create a suspension of skin cells that can trigger healing in chronic wounds, such as venous leg ulcers and diabetic foot ulcers.

78%

re-pigmentation2

reduced

healing time, risk of infection and scarring4,6,7

ReNovaCell™ is a medical device that delivers a skin cell suspension for treating aesthetic applications: restoring pigmentation, and improving the appearance of scars, sun-damaged skin, wrinkles and lesions.

Twitter

follow

Thursday, May 25th, 2017 at 8:00am
The incidence of contracture on a wound treated with #autograft can be reduced by using ReCell as an adjunct #SprayOnSkin #WoundTreatment https://t.co/T2pNoPz3GP AvitaMedical photo
2
Thursday, May 25th, 2017 at 8:00am
In around 30 mins, an autologous suspension is made cont. all cells + wound healing factors needed to regenerate healthy skin #BurnsCare https://t.co/wEf1XCU7iQ AvitaMedical photo
3
Wednesday, May 24th, 2017 at 10:00pm
#RES + #ReCell device gives wounds 'right messages + the right cell populations at the correct time' @proedros1998 https://t.co/mvjr9yQe2C https://t.co/HjVe4lCZ7i AvitaMedical photo
Wednesday, May 24th, 2017 at 5:00pm
#ReCell is used to create a Regenerative Epithelial Suspension (RES) which can be used with conventional #treatments for #BurnsProcedures https://t.co/SqxfSlliPt AvitaMedical photo
1

Facebook

follow

Avita Medical
Avita MedicalThursday, May 25th, 2017 at 11:00am

The incidence of contracture on a wound treated with #autograft can be reduced by using ReCell as an adjunct #SprayOnSkin #WoundTreatment

Avita Medical
Avita MedicalThursday, May 25th, 2017 at 4:00am

#AvitaMedical makes headlines again, showing #confidence in the company from the top down http://bit.ly/2qOpl4y

Share Price

Last Trade: 0.09 Last Trade: 1.34
High: 0.09 High: 1.34
Low: 0.08 Low: 1.26
Close: 0.09 Close: 1.48
Volume: 1,945,186 Volume: 28080
Prices are delayed by 20 minutes